Research course and value of artemisinin

Electronic Journal of Emerging Infectious Diseases ›› 2019, Vol. 4 ›› Issue (4): 193-195.

• Guidelines and Consensus • Next Articles

Research course and value of artemisinin

WANG Ji-gang¹, ZHU Yong-ping¹, XU Cheng-chao¹, YANG Jing², QIU Chen², LIAO Fu-long¹, JIANG Ting-liang¹, TU Youyou¹

1. Artemisinin Research Center, China Academy of Chinese Medical Sciences, Beijing 100700, china;
2. Shenzhen People's Hospital, Guangdong Shenzhen, 518020, China

Online:2019-12-30 Published:2020-07-21

Abstract

Abstract: Malaria has always been a devastating and life-threatening global infectious disease.Artemisinin-based combination therapies are the most effective treatment for malaria in the world, used in almost all endemic regions, and has successfully saved millions of lives. The discovery of artemisinin is the product of close combination of traditional Chinese medicine and modern science and technology. It is the effort and wisdom of a large number of Chinese scientists that eventually deliver artemisinin as a gift of traditional Chinese medicine to the world.

Key words: Malaria, Artemisinin, traditional Chinese medicine

WANG Ji-gang, ZHU Yong-ping, XU Cheng-chao, YANG Jing, QIU Chen, LIAO Fu-long, JIANG Ting-liang, TU Youyou. Research course and value of artemisinin[J]. Electronic Journal of Emerging Infectious Diseases, 2019, 4(4): 193-195.

References

[1] Tu Y.Artemisinin-A Gift from Traditional Chinese Medicine to the World (Nobel Lecture)[J]. Angew Chem Int Ed Eng, 2016, l55(35): 10210-10226.
[2] D'Alessandro U, Buttiens H. History and importance of antimalarial drug resistance[J]. Trop Med Int Health, 2001, 6(11): 845-848.
[3] Cox FE.History of the discovery of the malaria parasites and their vectors[J]. Parasit Vectors, 2010, 3(1): 5.
[4] Tu Y.The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine[J]. Nat Med, 2011, 17(10): 1217-1220.
[5] Jiang B, Li GQ, Guo XB, et al.Antimalarial activity of mefloquine and qinghaosu[J]. Lancet, 1982, 320(8293): 285-288.
[6] Looareesuwan S, Viravan C, Vanijanonta S, et al.Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria[J]. Lancet, 1992, 339(8797): 821-824.
[7] Dondorp AM, Fanello CI, Hendriksen CE.Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial[J]. Lancet, 2010, 376(9753): 1647-1657.
[8] Efferth T, Kaina B.Toxicity of the antimalarial artemisinin and its dervatives[J]. Crit Rev Toxicol, 2010, 40(5): 405-421.
[9] Haldar K, Bhattacharjee S, Safeukui I.Drug resistance in Plasmodium[J]. Nat Rev Microbiol, 2018, 16(3): 156-170.
[10] Krishna S, Kremsner PG.Antidogmatic approaches to artemisinin resistance: reappraisal as treatment failure with artemisinin combination therapy[J]. Trends Parasitol, 2013, 29(7): 313-317.
[11] Wang J, Xu C, Liao FL.et al.A Temporizing Solution to “Artemisinin Resistance”[J]. New Engl J Med, 2019, 380(22): 2087-2089.
[12] Gil JP, Krishna S. pfmdr1 (Plasmodium falciparum multidrug drug resistance gene 1): a pivotal factor in malaria resistance to artemisinin combination therapies[J]. Expert Rev Anti Infect Ther, 2017, 15(6), 527-543.

Research course and value of artemisinin

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 0

Recommended Articles

Metrics

Comments